You are here

Manufacturing Development of Biomimetic Tissue Engineering Scaffolds

Award Information
Agency: Department of Defense
Branch: Army
Contract: W81XWH-11-C-0022
Agency Tracking Number: A2-4733
Amount: $729,999.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: A10-115
Solicitation Number: 2010.2
Timeline
Solicitation Year: 2010
Award Year: 2012
Award Start Date (Proposal Award Date): 2012-01-28
Award End Date (Contract End Date): N/A
Small Business Information
7151 Discovery Drive
Chattanooga, TN -
United States
DUNS: 036255094
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: Yes
Principal Investigator
 Jayesh Doshi
 President
 (423) 267-6266
 jdoshi@eSpintechnologies.com
Business Contact
 Jayesh Doshi
Title: President
Phone: (423) 267-6266
Email: jdoshi@eSpintechnologies.com
Research Institution
 Stub
Abstract

With tissue engineering science offering promising biomedical interventions for previously untreatable injuries or diseases, many researchers are investigating the use of nanofiber-based medical vehicles for regenerative medicine. The challenge is to produce such vehicles outside of a small-scale laboratory environment and to develop a GMP-compliant lab to fabricate medical-grade devices for use in clinical trials. This proposed effort is targeted towards developing a cGMP compliant electrospinning technology to produce small lots of tissue scaffold material. During Phase II, an electrospinning machine will be built in a Class 1000 clean room and a small lot manufacturing process used to produce a clinical grade PLGA tissue scaffold. Process parameters will be established for meeting GMP/GLP guidelines and regulatory protocols established for the master file for devices. The electrospinning machines capacity, capability, and performance will be determined to establish a design space, cost of goods sold, and economics for producing the scaffolds in small lots. Electrospun fiber size, web thickness, pore size, and mechanical properties will be controlled to meet the design specifications of the device. The facility will meet production capacity with varied capability to provide tissue scaffold material for clinical trials at military and civilian sites.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government